Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Research Abstract |
TGF-beta1 is involved in diabetes nephropathy and focal segmental glomerulonephritis. Transcriptional factor Wilms tumor suppressor gene (WT1) is essential for normal function of podocytes. We found that TGF-beta1 reduces WT1 expression in both cultured humanpodocytes and mouse podocytes. Using the cultured podocytes, we identified following mechanisms by which TGF-beta1 suppress WT1 expression. First, Smad4 mediates a decrease in WT1 expression by TGF-beta1. Second, TGF-beta1 caused DNA methylation in promoter region of the podocytes. Our results indicate that diverse pathways contribute to the TGF-beta1-induced WT1 reduction that may result in podocyte injury.
|